Susquehanna International Group, LLP Armata Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 49,788 shares of ARMP stock, worth $98,082. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,788
Previous 29,786
67.15%
Holding current value
$98,082
Previous $70,000
31.43%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARMP
# of Institutions
25Shares Held
1.39MCall Options Held
0Put Options Held
10.3K-
Bank Of America Corp Charlotte, NC634KShares$1.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA234KShares$461,2140.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$210,3740.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$197,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX69.7KShares$137,2730.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $71.2M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...